Literature DB >> 24196622

Resection margins in pancreatic cancer.

C S Verbeke1.   

Abstract

The R1 rate and prognostic significance of microscopic margin involvement differ consistently between published series. This divergence results from a lack of consensus regarding various aspects of margin status assessment. Central to the controversies is the lack of clarity about what 'R1' exactly stands for. The current UICC definition--residual microscopic tumor--is possibly too general and invites divergent interpretations. Adherence to different diagnostic criteria for microscopic margin involvement and divergent terminology for the various margins of pancreatoduodenectomy specimens add to the confusion. Furthermore, recent studies demonstrated that the dissection technique and extent of tissue sampling influence the accuracy of margin assessment. Axial specimen slicing, extensive tissue sampling, and multicolored margin inking result in a significantly higher, more accurate R1 rate than when using traditional grossing techniques. Only when international consensus on these various aspects is reached will pathology data on margin involvement be reliable and can multicenter clinical trials produce compelling evidence that allows improved pancreatic cancer treatment.

Entities:  

Mesh:

Year:  2013        PMID: 24196622     DOI: 10.1007/s00292-013-1799-5

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  17 in total

1.  Most pancreatic cancer resections are R1 resections.

Authors:  Irene Esposito; Jörg Kleeff; Frank Bergmann; Caroline Reiser; Esther Herpel; Helmut Friess; Peter Schirmacher; Markus W Büchler
Journal:  Ann Surg Oncol       Date:  2008-03-20       Impact factor: 5.344

2.  Impact of margin status on survival following pancreatoduodenectomy for cancer: the Leeds Pathology Protocol (LEEPP).

Authors:  Krishna V Menon; Dhanwant Gomez; Andrew M Smith; Alan Anthoney; Caroline S Verbeke
Journal:  HPB (Oxford)       Date:  2009-02       Impact factor: 3.647

3.  Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators.

Authors:  T A Sohn; C J Yeo; J L Cameron; L Koniaris; S Kaushal; R A Abrams; P K Sauter; J Coleman; R H Hruban; K D Lillemoe
Journal:  J Gastrointest Surg       Date:  2000 Nov-Dec       Impact factor: 3.452

4.  Prognostic factors associated with resectable adenocarcinoma of the head of the pancreas.

Authors:  K W Millikan; D J Deziel; J C Silverstein; T M Kanjo; J D Christein; A Doolas; R A Prinz
Journal:  Am Surg       Date:  1999-07       Impact factor: 0.688

5.  Tumour growth is more dispersed in pancreatic head cancers than in rectal cancer: implications for resection margin assessment.

Authors:  Caroline Sophie Verbeke; Johannes Knapp; Ivar Prydz Gladhaug
Journal:  Histopathology       Date:  2011-12       Impact factor: 5.087

6.  Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy.

Authors:  C G Willett; K Lewandrowski; A L Warshaw; J Efird; C C Compton
Journal:  Ann Surg       Date:  1993-02       Impact factor: 12.969

7.  Microscopic margins and patterns of treatment failure in resected pancreatic adenocarcinoma.

Authors:  Jennifer L Gnerlich; Samuel R Luka; Anjali D Deshpande; Bernard J Dubray; Joshua S Weir; Danielle H Carpenter; Elizabeth M Brunt; Steven M Strasberg; William G Hawkins; David C Linehan
Journal:  Arch Surg       Date:  2012-08

8.  Margin clearance and outcome in resected pancreatic cancer.

Authors:  David K Chang; Amber L Johns; Neil D Merrett; Anthony J Gill; Emily K Colvin; Christopher J Scarlett; Nam Q Nguyen; Rupert W L Leong; Peter H Cosman; Mark I Kelly; Robert L Sutherland; Susan M Henshall; James G Kench; Andrew V Biankin
Journal:  J Clin Oncol       Date:  2009-04-27       Impact factor: 44.544

9.  Classification of R1 resections for pancreatic cancer: the prognostic relevance of tumour involvement within 1 mm of a resection margin.

Authors:  Fiona Campbell; Richard A Smith; Philip Whelan; Robert Sutton; Michael Raraty; John P Neoptolemos; Paula Ghaneh
Journal:  Histopathology       Date:  2009-09       Impact factor: 5.087

10.  Adjuvant chemoradiation for pancreatic adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study.

Authors:  Charles C Hsu; Joseph M Herman; Michele M Corsini; Jordan M Winter; Matthew D Callister; Michael G Haddock; John L Cameron; Timothy M Pawlik; Richard D Schulick; Christopher L Wolfgang; Daniel A Laheru; Michael B Farnell; Michael J Swartz; Leonard L Gunderson; Robert C Miller
Journal:  Ann Surg Oncol       Date:  2010-01-20       Impact factor: 5.344

View more
  13 in total

1.  Impact of adjuvant treatment modalities on survival outcomes in curatively resected pancreatic and periampullary adenocarcinoma.

Authors:  Nedim Turan; Mustafa Benekli; Olcun Umit Unal; İlkay Tugba Unek; Didem Tastekin; Faysal Dane; Efnan Algın; Sukran Ulger; Tulay Eren; Turkan Ozturk Topcu; Esma Turkmen; Nalan Akgül Babacan; Gulnihal Tufan; Zuhat Urakci; Basak Oven Ustaalioglu; Ozlem Sonmez Uysal; Ozlem Balvan Ercelep; Burcu Yapar Taskoylu; Asude Aksoy; Mustafa Canhoroz; Umut Demirci; Erkan Dogan; Veli Berk; Ozan Balakan; Ahmet Şiyar Ekinci; Mukremin Uysal; İbrahim Petekkaya; Selçuk Cemil Ozturk; Önder Tonyalı; Bülent Çetin; Mehmet Naci Aldemir; Kaan Helvacı; Nuriye Ozdemir; İlhan Oztop; Ugur Coskun; Aytug Uner; Ahmet Ozet; Suleyman Buyukberber
Journal:  Chin J Cancer Res       Date:  2015-08       Impact factor: 5.087

2.  SPECIFIC MOLECULAR RECOGNITION AS A STRATEGY TO DELINEATE TUMOR MARGIN USING TOPICALLY APPLIED FLUORESCENCE EMBEDDED NANOPARTICLES.

Authors:  Shawn Barton; Bo Li; Michael Siuta; Janve Vaibhav; Jessica Song; Clinton M Holt; Takumi Tomono; Masami Ukawa; Hironori Kumagai; Etsuo Tobita; Kevin Wilson; Shinji Sakuma; Wellington Pham
Journal:  Precis Nanomed       Date:  2018-10-29

3.  Impact of margin status and lymphadenectomy on clinical outcomes in resected pancreatic adenocarcinoma: implications for adjuvant radiotherapy.

Authors:  Arsen Osipov; Jason Naziri; Andrew Hendifar; Deepti Dhall; Joanne K Rutgers; Shefali Chopra; Quanlin Li; Mourad Tighiouart; Alagappan Annamalai; Nicholas N Nissen; Richard Tuli
Journal:  J Gastrointest Oncol       Date:  2016-04

Review 4.  [What is new in the pathology of pancreatic neuroendocrine tumors?].

Authors:  P Komminoth; A Perren
Journal:  Pathologe       Date:  2015-05       Impact factor: 1.011

5.  Response to: Commentary on: "Nationwide Validation of the 8th American Joint Committee on Cancer TNM Staging System and Five Proposed Modifications for Resected Pancreatic Cancer".

Authors:  T J Schouten; L A Daamen; H C van Santvoort; I Q Molenaar
Journal:  Ann Surg Oncol       Date:  2022-08-04       Impact factor: 4.339

6.  Superior mesenteric-portal vein resection during laparoscopic pancreatoduodenectomy.

Authors:  Igor E Khatkov; Roman E Izrailov; Arthur A Khisamov; Pavel S Tyutyunnik; Abraham Fingerhut
Journal:  Surg Endosc       Date:  2016-07-21       Impact factor: 4.584

Review 7.  Does the Volume-Outcome Association in Pancreas Cancer Surgery Justify Regionalization of Care? A Review of Current Controversies.

Authors:  Alexandra W Acher; Sharon M Weber; Timothy M Pawlik
Journal:  Ann Surg Oncol       Date:  2021-09-14       Impact factor: 5.344

8.  Towards a More Standardized Approach to Pathologic Reporting of Pancreatoduodenectomy Specimens for Pancreatic Ductal Adenocarcinoma: Cross-continental and Cross-specialty Survey From the Pancreatobiliary Pathology Society Grossing Working Group.

Authors:  Deepti Dhall; Jiaqi Shi; Daniela S Allende; Kee-Taek Jang; Olca Basturk; Volkan Adsay; Grace E Kim
Journal:  Am J Surg Pathol       Date:  2021-10-01       Impact factor: 6.298

9.  Influence of Body Mass Index and Albumin on Perioperative Morbidity and Clinical Outcomes in Resected Pancreatic Adenocarcinoma.

Authors:  Andrew Hendifar; Arsen Osipov; Jasleen Khanuja; Nicholas Nissen; Jason Naziri; Wensha Yang; Quanlin Li; Richard Tuli
Journal:  PLoS One       Date:  2016-03-25       Impact factor: 3.240

10.  Laparoscopic uncinate process first pancreatoduodenectomy-feasibility study of a modified 'artery first' approach to pancreatic head cancer.

Authors:  Michał Pędziwiatr; Magdalena Pisarska; Piotr Małczak; Piotr Major; Mateusz Wierdak; Dorota Radkowiak; Jan Kulawik; Marcin Dembiński; Andrzej Budzyński
Journal:  Langenbecks Arch Surg       Date:  2017-07-11       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.